Upadacitinib Amide Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Upadacitinib Amide Impurity

● In Stock

Catalogue No.:VE0027852
CAS No.:N/A
Mol. Formula:C15H18N6O
Mol. Weight:298.34 g/mol

Additional information on

Parent drug

Upadacitinib

IUPAC Name

(3S,4R)-3-ethyl- 4-(3H-imidazo[1,2-a]pyrrolo[2,3- e]pyrazin-8-yl)pyrrolidine-1- carboxamide

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=C(N1C[C@@H](CC)[C@@H](C2=CN=C3C=NC(NC=C4)=C4N32)C1)N

InChI

InChI=1S/C15H18N6O/c1-2-9-7-20(15(16)22)8-10(9)12-5-18-13-6-19-14-11(21(12)13)3-4-17-14/h3-6,9-10,17H,2,7-8H2,1H3,(H2,16,22)/t9-,10+/m1/s1

Description

Upadacitinib Amide Impurity is a process-related organic impurity consistent with amidation or hydrolytic rearrangement of the parent heteroaromatic framework rather than a structural class associated with direct genotoxic alerting motifs. With molecular formula C15H18N6O and molecular weight 298.34 g/mol, it represents a defined degradant or synthesis byproduct that may arise during late-stage coupling, moisture exposure, or amidation steps. Its characterization typically relies on LC-MS/MS for mass confirmation, complemented by LC-UV and high-resolution MS to resolve closely related analogues. Regulatory assessment follows impurity qualification principles, with emphasis on origin, carryover, and chromatographic specificity.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url